• <input id="ycg2u"></input>
    <legend id="ycg2u"></legend>
    <strong id="ycg2u"><u id="ycg2u"></u></strong>
  • Enable Accessibility Enable Accessibility

    Revision of Takeda’s Executive Compensation Overview

    August 6, 2021

    OSAKA, Japan, August 6, 2021 – Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) revised one of the KPIs for executive compensation on July 30, 2021. This revision is to update Fiscal Year 2021-2023 Performance Share Units (PSU) KPIs for Long-Term Incentive Compensation Plans from “Core Operating Profit Margin” to “Aggregated FY21-23 Underlying Core Operating Profit Margin” to reflect that it measures the aggregated margin over the FY2021-2023 performance period.

    Please visit here for the revised “Takeda’s Executive Compensation Overview”.

    国产AV网站_中午文字幕av一区二区三区_性进入裸体视频_久久久久久精品免费免费直播